Coronary vasodilator reserve and Framingham risk scores in subjects at risk for coronary artery disease

Sharmila Dorbala1, Alita Hassan, Therese Heinonen

  • 1Division of Nuclear Medicine/PET, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA. sdorbala@partners.org

Insights

Coronary flow reserve (CFR) decreases as coronary heart disease (CHD) risk increases in individuals without diagnosed coronary artery disease (CAD). This finding highlights CFR as a potential indicator for early CHD risk assessment.

Area of Science:

  • Cardiovascular Imaging
  • Nuclear Cardiology
  • Preventive Cardiology

Background:

  • The predictive value of coronary vasodilator reserve for coronary heart disease (CHD) risk in individuals without established coronary artery disease (CAD) remains unclear.
  • Assessing subclinical cardiovascular disease is crucial for refining risk stratification and guiding preventive strategies.

Purpose of the Study:

  • To investigate the relationship between coronary flow reserve (CFR) and estimated 10-year CHD risk in a cohort of subjects without clinical CAD.
  • To determine if measures of coronary microvascular function correlate with established CHD risk scores.

Main Methods:

  • Positron emission tomography (PET) with adenosine and N-13 ammonia was used to measure CFR and coronary vascular resistance (CVR) at rest and during hyperemia.
  • 289 subjects without overt CAD, stratified by Framingham CHD risk scores (low vs. intermediate), were analyzed.
  • Correlations between CFR, CVR, and Framingham-estimated CHD risk were calculated.

Main Results:

  • Subjects with intermediate CHD risk exhibited significantly lower CFR (2.5 ± 0.8) and higher minimal CVR (52.4 ± 16.4) compared to low-risk subjects (CFR 2.8 ± 1.0, CVR 49.3 ± 17.41).
  • CFR showed a significant inverse relationship with CHD risk (R = -0.2, P = .006).
  • CVR demonstrated a significant direct relationship with CHD risk (R = 0.2, P < .001).

Conclusions:

  • In individuals without clinical CAD but with low to intermediate CHD risk, CFR measured by PET is inversely associated with estimated 10-year CHD risk.
  • These findings suggest that impaired coronary microvascular function, as indicated by reduced CFR, may be an early marker of increased CHD risk.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...